Prostate Cancer Screenings
Committed to Increasing Prostate Cancer Survival
In addition to an annual physical examination that includes blood, urine and possibly other laboratory tests, the American Urological Association and the American Cancer Society suggest consulting your physician about recommendations for the evaluation of the prostate gland.
IN THE NEWS
10/11/11: A New Debate: Is Prostate Cancer Screening Really Necessary?
Both the local and national media are clamoring over it; it being a recommendation made from a government panel released last week that finds the PSA (prostate-specific antigen) blood test used in detecting prostate cancer does more harm than good. From the desk of CBS Evening News to NBC’s The Today Show to our local Atlanta paper, the Atlanta Journal Constitution, men are receiving loud, unclear messages about how to approach prostate care and health. In an effort to clear up the confusion over what has become a controversial debate, our Prostate Cancer Center at Saint Joseph’s Hospital Chairman, Rajesh Laungani, M.D. weighs in on the topic. >> SAINT JOSEPH’S HOSPITAL OF ATLANTA STATEMENT REGARDING RECENT U.S. PREVENTATIVE SERVICES TASK FORCE (USPSTF) RULING ON PSA SCREENING .
Click here for the American Urological Association Best Practice Statement.
Successful prostate cancer screening held at Saint Joseph's on September 10, 2011
>> MORE PHOTOS<<
If you attended the screening, tell us how we did! Click here to complete a short survey.
Free Prostate Cancer Screenings at Saint Joseph's
The Prostate Cancer Center at Saint Joseph's is committed to screening as a method to continually increase prostate cancer survival. We follow the American Urological Association (AUA) Guidelines for Prostate Cancer Screening which recommends a baseline prostate-specific antigen blood test (PSA) along with a digital rectal exam (DRE) beginning at age 40. Following the initial screening, annual screenings should be done to track changes in the PSA level (and the prostate itself) which can be an indication of a problem. Please check our Web site often for information about free community screening events. All screenings for prostate cancer at Saint Joseph's are done by appointment only and are for men between the age of 40 and 75 who have never been diagnosed with prostate cancer. Learn More about upcoming screening events here >> Upcoming Screenings
Prostate Cancer Screening consists of:
Prostate-specific antigen (PSA) blood test & digital rectal exam (DRE)
Eligibility:
Men between 40-75 years of age who have never been diagnosed with prostate cancer.
Men who have not been screened for prostate cancer within the past 12 months.
By appointment only.
Call (678) 843-5665 or email rsevy@sjha.org for more information
or to schedule an appointment at an upcoming screening event.
Something to consider: Help Further Prostate Cancer Research
In 2010, Saint Joseph’s Hospital embarked on an ambitious prostate cancer tissue banking study with Georgia Tech and Clark Atlanta University. The idea is to study the genetics of these cancers in an attempt to identify genetic markers. The hope is that this research will contribute to increased survival and improved treatment for prostate and bladder cancers. The study requires that we have control group of “healthy normal” blood and urine samples so we are asking men who have never been diagnosed with prostate or bladder cancer to participate. This is a one-time donation and your identity will remain completely anonymous. Click here to read more about it.
You will be asked at the prostate cancer screening event whether you are willing to participate but please do not feel obligated in any way. Participation is completely voluntary and there is no financial compensation for your participation. Questions regarding this study should be directed to Judy Smith, RN, Clinical Research Nurse with the Oncology Research Department at Saint Joseph's, at (678) 843-7119.
Information on this page is provided collaboratively by the team at the Prostate Cancer Center at Saint Joseph's and has been medically reviewed by Rajesh G. Laungani, MD, 2010. Claims regarding treatment are based on years of clinical experience and industry reported data. The PCC follows American Urological Association and National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for the treatment of prostate cancer.
Last Updated: November 2, 2011 (RSH)
